Oncology Business Management | Specialty

The OncLive Oncology Business Management condition center page is a comprehensive resource for news and expert insights on business-focused updates and topics in oncology practices, including diversity efforts, telehealth, gaps in care, payment models, and more. This page features news articles, interviews in written and video format, and podcasts that focus on updates and best practices with oncology business management.

An Update on Molecular Testing in Colorectal Cancer

July 12th 2016

Putting in Longer Hours for World-Class Care

July 11th 2016

Ventura County Hematology Oncology Specialists opened its doors 45 years ago and has long occupied a comfortable niche in its local market.

Chasing the Holy Grail of EHR Interoperability

July 8th 2016

COTA Inc, an independent health care informatics company was founded to build research-grade, real-world data to exponentially improve outcomes and reduce costs—ensuring the right care for the right patient every time.

FDA Releases Draft Guidances on Next-Generation Sequencing

July 7th 2016

The FDA has issued two draft guidances that will provide regulatory oversight for the use of next-generation sequencing-based tests.

Ibrutinib Granted Breakthrough Designation for Chronic GVHD

June 30th 2016

The FDA has granted a breakthrough therapy designation to ibrutinib has a potential treatment for patients with chronic graft-versus-host-disease after failure of one or more lines of systemic therapy.

CMS Announces Practices Participating in OCM and Launch Date

June 30th 2016

A year after announcing its intention to launch the Oncology Care Model alternative payment plan for oncology care, The Centers for Medicare & Medicaid Services said it has 196 practices enrolled across the United States and that the official start date is Friday, July 1.

Pazdur Named Head of New Oncology Center of Excellence

June 30th 2016

Richard Pazdur, MD, has been named the acting director of the FDA's newly created Oncology Center of Excellence, which is aimed to expedite the development of novel combination products and support an integrated approach to oncology research.

FDA Panel Endorses Early Trials of Promising Anticancer Agents in Pediatric Patients

June 29th 2016

Members of the Pediatric Subcommittee of the FDA's Oncologic Drugs Advisory Committee voiced their support for new clinical trials examining promising cancer agents in pediatric patients.

A Look to the Future in RCC

June 29th 2016

A Changing Landscape in RCC

June 29th 2016

Novel Approaches in Advanced RCC

June 29th 2016

Long-Term RCC Data with Nivolumab

June 29th 2016

Second and Third-Line Decisions in RCC

June 29th 2016

The Role of Lenvatinib in Advanced RCC

June 29th 2016

Options in the Third Line Setting for RCC

June 29th 2016

The Rationale for Cabozantinib in Advanced RCC

June 29th 2016

Patient Selection and Checkpoint Inhibition in RCC

June 29th 2016

Advanced RCC Sequencing Challenges

June 29th 2016

Assessing Treatment Response with RCC First-Line Therapies

June 29th 2016

RCC First-Line Toxicity Considerations

June 29th 2016